| A new marker for lipid peroxidation: Serum paraoxonase activity in non-alcoholic steatohepatitis | Mevlüt BAŞKOL,Gülden BAŞKOL,Kemal DENİZ,Ömer ÖZBAKIR,Mehmet YÜCESOY | 119–123 |
| Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment | Galip ERSÖZ,Fulya GÜNŞAR,zeki karasu,Sinan AKAY,Yücel BATUR,ULUS SALİH AKARCA | 124–128 |
| Importance of anticoagulant proteins in chronic liver diseases | Şebnem GÜRSOY,Mevlüt BAŞKOL,Edip TORUN,Alper YURCİ,Işın SOYUER,Bülent ESER,Kadri GÜVEN,Ömer ÖZBAKIR,Mehmet YÜCESOY | 129–133 |
| Ultrasound-guided percutaneous cholecystostomy for acute cholecystitis in critically ill patients: One center’s experience | Özgür BAŞARAN,Nazlı YAZVUZER,Haldun SELÇUK,Ali HARMAN,Hamdi KARAKAYALI,Nevzat BİLGİN | 134–137 |
| The use and safety profile of non-steroidal anti-inflammatory drugs among Turkish patients with osteoarthritis | HÜRRİYET GÜRSEL YILMAZ,Selim GÜREL,Oktay ÖZDEMİR | 138–142 |
| Relationship between HLA-DR, HLA-DQ alleles and MEFV gene mutations in familial mediterranean fever (FMF) patients | GÜLAY KINIKLI,Mehmet BEKTAŞ,Müge MISIRLIOĞLU,AŞKIN ATEŞ,Murat TURGAY,Serdar TUNCER,Sami KINIKLI,Güner TOKGÖZ | 143–146 |
| Can we rely on public data as a source of information for cancer registry in developing countries? | Shahyar SEMNANI,Mohammad Javad KABIR,Sima BESHARAT,Nafiseh ABDOLAHI,Ahmad DANESH,Danial ROSHANDEL | 147–149 |
| Gamna-Gandy bodies: A sign of portal hypertension | Doğan SELÇUK,Kemal DEMİREL,Fatih KANTARCI,İsmail MİHMANLI,ASIM GÜNDÜZ ÖĞÜT | 150–152 |
| Hepatocavopathy and isolated splenic vein thrombosis due to hypercoagulability state | Mesut AKARSU,Mustafa SEÇİL,Serkan YENER,Ömer TOPALAK | 153–155 |
| Pancreatic mass lesion mimicking carcinoma: Initial presentation of retroperitoneal fibrosis | Muhsin KAYA,Fatih AYDIN | 156–159 |
| Gastric heterotopia together with intestinal metaplasia in the gallbladder: Case report and review of literature | LEMA TAVLI,Metin BELVİRANLI,Mehmet ERİKOĞLU,Hasan ESEN,Hatice TOY |